AgingResearch.NewsJoin free

ROS scavengers

Intervention

1 paper1 finding

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 1 lab in 1 country
  • Funders: Department of Science and Technology, Ministry of Science and Technology, India and 1 more
  • Model organisms1

Outcomes

1

Lifespan

upin worms1

1 study

  1. ROS scavengers extend lifespan in worms.

    “interventions such as administering ROS scavengers and autophagy modulators offered a reprieve from this life-shortening effect.”

    Model organismsT13F2.2 knockdown

    T13F2.2 of C. elegans is Critical for Chromatin Organization, Autophagy, and Longevity

    bioRxiv (Cold Spring Harbor Laboratory)22 Sep 2025Preprint

Latest

Related